148 related articles for article (PubMed ID: 38404197)
1. Antidepressant Dispensing to US Adolescents and Young Adults: 2016-2022.
Chua KP; Volerman A; Zhang J; Hua J; Conti RM
Pediatrics; 2024 Mar; 153(3):. PubMed ID: 38404197
[TBL] [Abstract][Full Text] [Related]
2. Association between the COVID-19 outbreak and opioid prescribing by U.S. dentists.
Zhang J; Nalliah RP; Waljee JF; Brummett CM; Chua KP
PLoS One; 2023; 18(11):e0293621. PubMed ID: 37917644
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 pandemic on antidepressant and antipsychotic use among children and adolescents: a population-based study.
Antoniou T; Pajer K; Gardner W; Penner M; Lunsky Y; Tadrous M; Mamdani M; Gozdyra P; Juurlink DN; Gomes T
Front Pediatr; 2023; 11():1282845. PubMed ID: 38146536
[TBL] [Abstract][Full Text] [Related]
4. Dispensing of HIV and Hepatitis C Antivirals During COVID-19: An Interrupted Time-Series Analysis of U.S. National Data.
Levengood TW; Aronsohn AI; Chua KP; Conti RM
Am J Prev Med; 2022 Oct; 63(4):532-542. PubMed ID: 35738958
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant dispensing trends in New Zealand between 2004 and 2007.
Exeter D; Robinson E; Wheeler A
Aust N Z J Psychiatry; 2009 Dec; 43(12):1131-40. PubMed ID: 20001412
[TBL] [Abstract][Full Text] [Related]
6. Prescription Drug Dispensing to US Children During the COVID-19 Pandemic.
Chua KP; Volerman A; Conti RM
Pediatrics; 2021 Aug; 148(2):. PubMed ID: 34285080
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009-2012: focus on children, adolescents and prescriber specialty.
Karanges EA; Stephenson CP; McGregor IS
Aust N Z J Psychiatry; 2014 Oct; 48(10):917-31. PubMed ID: 24927734
[TBL] [Abstract][Full Text] [Related]
8. Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex - United States, March 2019 - December 2020.
Cremer LJ; Board A; Guy GP; Schieber L; Asher A; Parker EM
Drug Alcohol Depend; 2022 Mar; 232():109192. PubMed ID: 35065513
[TBL] [Abstract][Full Text] [Related]
9. Changes in antidepressant use in Australia: A nationwide analysis (2015-2021).
de Oliveira Costa J; Gillies MB; Schaffer AL; Peiris D; Zoega H; Pearson SA
Aust N Z J Psychiatry; 2023 Jan; 57(1):49-57. PubMed ID: 35176912
[TBL] [Abstract][Full Text] [Related]
10. Impact of class-level labelling change on prescriptions of antidepressants for adolescents: An interrupted time-series study using a health insurance claims database in Japan, 2005-2013.
Ogino Y; Schmidt AJ
PLoS One; 2020; 15(12):e0243424. PubMed ID: 33284822
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study.
Jack RH; Hollis C; Coupland C; Morriss R; Knaggs RD; Butler D; Cipriani A; Cortese S; Hippisley-Cox J
PLoS Med; 2020 Jul; 17(7):e1003215. PubMed ID: 32697803
[TBL] [Abstract][Full Text] [Related]
12. The effects of COVID-19 on the dispensing rates of antidepressants and benzodiazepines in Canada.
Uthayakumar S; Tadrous M; Vigod SN; Kitchen SA; Gomes T
Depress Anxiety; 2022 Feb; 39(2):156-162. PubMed ID: 34843627
[TBL] [Abstract][Full Text] [Related]
13. Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study.
Antoniou T; McCormack D; Kitchen S; Pajer K; Gardner W; Lunsky Y; Penner M; Tadrous M; Mamdani M; Juurlink DN; Gomes T
BMC Public Health; 2023 Jan; 23(1):85. PubMed ID: 36631810
[TBL] [Abstract][Full Text] [Related]
14. IDI trends in antidepressant dispensing to New Zealand children and young people between 2007/08 and 2015/16.
Bowden N; Gibb S; Thabrew H; Audas R; Camp J; Taylor B; Hetrick S
N Z Med J; 2019 Nov; 132(1505):48-61. PubMed ID: 31697663
[TBL] [Abstract][Full Text] [Related]
15. The impact of cost sharing on antidepressant use among older adults in British Columbia.
Wang PS; Patrick AR; Dormuth CR; Avorn J; Maclure M; Canning CF; Schneeweiss S
Psychiatr Serv; 2008 Apr; 59(4):377-83. PubMed ID: 18378836
[TBL] [Abstract][Full Text] [Related]
16. Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the Coronavirus Disease 2019 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data.
Chua KP; Fischer MA; Rahman M; Linder JA
Clin Infect Dis; 2024 Apr; ():. PubMed ID: 38648159
[TBL] [Abstract][Full Text] [Related]
17. State-to-State Variation in Opioid Dispensing Changes Following the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain.
Lyu X; Guy GP; Baldwin GT; Losby JL; Bohnert ASB; Goldstick JE
JAMA Netw Open; 2023 Sep; 6(9):e2332507. PubMed ID: 37695587
[TBL] [Abstract][Full Text] [Related]
18. Impacts of the New York State COVID-19 disaster emergency orders on prescription dispensing for opioids and medication for opioid use disorder.
Suri A; Feaster DJ; Balise RR; Quinn J; Nunes EV; Gilbert L; El-Bassel N; Rundle AG
Addiction; 2023 Apr; 118(4):711-718. PubMed ID: 36398540
[TBL] [Abstract][Full Text] [Related]
19. Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID-19 pandemic, 2013-2021: a retrospective cohort study.
Wood SJ; Ilomäki J; Gould J; Tan GS; Raven M; Jureidini JN; Grzeskowiak LE
Med J Aust; 2023 Jul; 219(1):18-25. PubMed ID: 37182907
[TBL] [Abstract][Full Text] [Related]
20. Increased incident rates of antidepressant use during the COVID-19 pandemic: interrupted time-series analysis of a nationally representative sample.
Frangou S; Travis-Lumer Y; Kodesh A; Goldberg Y; New F; Reichenberg A; Levine SZ
Psychol Med; 2023 Aug; 53(11):4943-4951. PubMed ID: 35680620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
